Prognostic Assessment

S-100 B protein in serum is an independent prognostic factor in malignant melanoma in clinical Stage II and III

E.Djureen-Mårtensson MD , L.O.Hansson MD, PhD , B.Nilsson BS , J.Hansson MD, PhD , E.von Schoultz MD, PhD , U.Ringborg MD, PhD

Quantifying the predictive factors of patient prognosis: How predictable are the presently used prognostic factors?

K Akazawa PhD , T Nakamura PhD , N Kinukawa MS , Y Nose MD PhD

Relationships between features of image analysis and histologic grading of breast carcinomas as well as the early clinical course of defined subsets of ductal carcinomas

H-V Tuczek MD, P Fritz MD, P Schwarzmann Dipl Ing, X Wu Dipl Ing, G Mähner Dipl Ing

Prognostic significance of alterations of cell cycle proteins in human brain tumors

D Schiffer, R Piva, S Bortolotto, I Cancelli, R Grosso, P Cavalla

Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients

V Liso MD , P Iacopino MD , G Avvisati MD , MC Petti MD , G Broccia MD , M Carotenuto MD , M Falda MD , P Fazi MD , M Lazzarino MD

Android obesity at diagnosis and breast cancer survival

NB Kumar PhD, K Allen RD, A Cantor PhD, J Perkins PharmD, CE Cox MD

Anti-p53 antibodies detection in cancer patients

MT Vietri MD, P Gazzerro BD, M Cioffi MD, C DiMacchia MD, C Abbondanza MD, B DiFinizio MD, GA Puca MD, AM Molinari MD

Serum anti-p53 antibodies and progression of hepatic diseases HCV related

P Gazzerro BD, M Cioffi MD MT Vietri MD, C Abbondanza MD, V Nigro MD, SA Raimondi MD, T Catalano BD, GA Puca MD, AM Molinari MD

Cerebellar astrocytoma: experience with 54 cases surgically treated at the Mayo Clinic, Rochester, Minnesota, from 1978 to 1990

VM Morreale MD , MJ Ebersold MD , LM Quast RN , JE Parisi MD

Prognostic factors in neuroblastoma

T Eckschlager MD PhD, A Vicha MD, P Kavan MD, J Stankova MD, J Malis MD, M Chanova MD, P Gajdos PhD, J Koutecky MD DSc

Clinical value of a tumor marker panel in the management of patients with squamous cell carcinoma of the head and neck

PD Goumas MD , NS Mastronikolis MD , AN Mastorakou MD , TA Papadas MD , SS Naxakis MD , ES Papadeas MD , PJ Vassilakos MD

Discrepancy between the efficacy of chemo-therapy and the survival time in advanced head and neck (H&N) cancer. I. The routine data and the chemotherapy efficacy

P Khoueiry MD , Ch Himberlin MD , K Moutel MD , JC Merol MD , P Coninx MD, PhD

Discrepancy between the efficacy of chemotherapy and the survival time in advanced head and neck (H&N) cancer: Routine data and survival time

K Moutel MD, X Panis , JC Merol MD, P Coninx MD, PhD

Correlation between the immunohistochemical and mRNA expression of glutathione S-transferase-pi and cisplatin plus etoposide chemotherapy response in patients with untreated primary non-small cell lung cancer

T Arai , Y Yasuda , T Takaya , N Yoshimi , H Ito and H Fujiwara

Altered expression of P53 and its regulated proteins in phyllodes tumours of the breast

V Kuenen-Boumeester MD PhD , SC Henzen-Logmans MD PhD , MM Timmermans BSc , IL Van Staveren BSc , A Van Geel MD PhD , HL Peeterse MD , J Bonnema MD PhD , EMJ

The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters

V Kuenen-BoumeesterMD PhD, ThH Van Der Kwast MD PhD, CC Claassen BSc, MP Look, JGM Klijn MD PhD, SC Henzen-Logmans MD PhD

Predictive value of serum medroxyprogesterone acetate (MPA) concentration for response in advanced or recurrent breast cancer

R Nishimura MD and K Nagao MD

Development of enzyme immunoassay of 2'-deoxycytidine as a prognostic marker

M Yoshioka, I Darwish, K Hirose, N El-Rabbat

Menstrual cycle does not affect the biopathological profile of primary breast cancer

C Botti , G Vitelli , G Digiesi , R Pace , E Capoluongo , F Sciarretta , M Mottolese .

Expression of Mad1 protein is inversely related with Myc expression in human breast cancer tissue

SH Han MD, KM Park MD, HY Kim MD, MS Lee MD, HJ Kim MD, YD Kim MD

Multiparametric prognostic evaluation of biological factors in axillary node negative breast cancer

Q Liu MD, YS Wang MD, LT Xing MD, M Li MD, JJ Liu BS

Timing of breast cancer surgery during menstrual cycle: A 5-year analysis of 248 pre-menopausal women

M Milella, AM D'Ottavio, V Ferraresi, A Vaccaro, A Fabi, C Nisticò, P Papaldo, C Botti, P Vici, M Lopez, E Terzoli and F Cognetti

Utilization of molecular (P53, PCNA, HER-2/NEU) and cytokinetic (ploidy, SPF, PI) parameters in pre-treatment identification of high risk patients with endometrial carcinoma

MB Silverman MD, R Kho MD, H. LI PhD, KC Podratz MD PhD

Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis

T Tsurusaki MD, S Kanda MD, H Sakai MD, H Kanetake MD, Y Saito MD,T Koji PhD

PCR for PSA is a strong preoperative predictor of PSA recurrence after radical prostatectomy

A de la Taille MD, CA Olsson MD, E Bagiella PhD, R Buttyan PhD, AE Katz MD

Renal function and serum levels of TATI (tumor-associated trypsin inhibitor)

G Tramonti MD , M Ferdeghini MD , C Donadio MD , C Annichiarico , M Norpoth MD , R Bianchi MD , C Bianchi MD

Prognostic potential of tumor cytokinetic parameters in patients with liver metastases from colon cancer - a multivariate approach

A Kozubik PhD , L Dusek , J Zaloudik , J Hofmanova PhD

Expression of CD44, ICAM-1 and N-CAM in colorectal cancer. Correlation with the tumor stage and the phenotypical characteristics of tumor-infiltrating lymphocytes

Dr. S Wimmenauer , G Wolff-Vorbeck PhD , J Müller , S Rahner MD , Dr. G Kirste , Dr. S von Kleist , and Dr. EH Farthmann

Expression of nm23-H1 in advanced colorectal cancer

Y Tabuchi, MD PhD, T Nakamura, MD, S Suzuki, MD, K Kawasaki, MD, M Ohno, MD

Laproscopic prediction of hepatocellular carcinoma in cirrhosis patients

Y Kameda, MD

DNA content and survival rates of patients with hepatocellular carcinoma

H Al-Abadi MD, S Jonas MD, WO Bechstein MD, Prof P Neuhaus MD

Quantification of circulating hepatocellular carci-noma cells in the peripheral blood of patients with hepatocellular carcinoma

IHN Wong PhD , PJ Johnson MD , T Leung MD, W Yeo , S Ho PhD, WY Lau

Extramedullary blast crisis in chronic myeloid leukemia

G Specchia MD, G Palumbo MD, D Pastore MD, A Mestice BSc, F Albano MD, MR Coppi BSc, D Mininni BSc, V Liso MD

Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: Lack of residual donor hematopoiesis predicts aplasia

Felix Keil, Oskar A. Haas, Gerhard Fritsch, Peter Kalhs, Klaus Lechner, Christine Mannhalter, Elisabeth Reiter, Werner Rabitsch, Paul Hoecker, Dietger Niederwieser and Hildegard T. Greinix

Primary mediastinal germ cell tumor with intratubular germ cell neoplasia of the testis - further support for germ cell origin of these tumors

S Hailemariam MD, DS Engeler, PU Heitz

Paradoxical sensitization to TNF, etoposide and H202 in L929 fibrosarcoma cells expressing a transfected 27 kDa heat shock protein (hsp27) gene

N Mairesse PhD, D Bernaert PhD, S Horman PhD, G Del Bino PhD and P Galand PhD

Expression of hepatitis B virus X protein in chronic liver diseases and in hepatocellular carcinoma

J Molnar MD DSC, I Marczinovits MD, P Nemeth MD DSc, , Gy Szekeres, MD

The impact of cancer diagnosis on patients quality of life

ER Greimel PhD, V Popper

DNA content of nasopharyngeal carcinoma: An independent prognostic indicator

MM Hsu MD,CR Chiou DDS,JY Ko MD,TS Sheen MD and PJ Lo MD

Estimation of radiosensitivity by fluorescent in situ hybridization of lymphocytes from patients with thyroid carcinoma

A Gaussen M Sc, D Violot, N Béron-Gaillard Ph D, JD Légal, R M'Kacher Ph D, C Parmentier MD

Non-small cell lung cancer (NSCLC). A DNA flow cytometric and clinico-pathologic study of 72 cases with a follow-up of 5 years

L Desinan MD

Predicting the patient at low risk for lymph node metastasis with localized prostate cancer: An analysis of four statistical models

LM Spevack MD , LT Killion MD , JC West Jr MD , GM Rooker MD , EA Brewer MD , PG Cuddy Pharm MD

Role of fine needle aspiration in management of lymphadenopathy in children and adolescents

I Ramzy MD,TB Ponder MD, D Smith CT

A comparison of two health care systems in the United States: How access to care affects differences in breast cancer survival

BE Wojcik, PhD, MK Spinks, MA, MSW